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Background:  Left ventricular ejection fraction (LVEF) may be evaluated in restrospectively gated coronary computed tomographic angiography 
(CCTA) however large multicenter studies validating the prognostic value of CCTA and LVEF are lacking. We sought to confirm the incremental 
prognostic value of LVEF measured using 64-slice CCTA over coronary artery disease (CAD) severity and clinical variables.
Methods:  A large international multicenter registry (CONFIRM Registry) was screened for LVEF assessment. Patients with a history of myocardial 
infarction, coronary revascularization or cardiac transplantation were excluded. The pretest probability for CAD and NCEP/ATP III risk were calculated 
for each patient and CCTA was evaluated for CAD severity (non-obstructive CAD, high risk CAD and non-high risk CAD) and LVEF < 50%. Patients were 
followed for all-cause mortality.
Results:  27,125 patients underwent CCTA at 12 participating centres with a total of 7,165 patients meeting the analysis criteria. Follow-up 
was available for 7,071 (98.7%) patients (mean follow-up of 19.3±9.1 months). All-cause mortality (120 deaths) was 0.44% of patients without 
coronary atherosclerosis, 1.94% of patients with non-obstructive CAD, 3.15% of patients with non-high risk CAD, and 5.83% for patients with high risk 
CAD. Multivariable analysis confirmed that CAD severity (Hazard Ratio (HR): 1.77;CI:1.44-2.17) and LVEF <50% (HR:4.43;CI:3.05-6.44) were both 
independent predictors of all-cause mortality and LVEF had incremental value over CAD severity and clinical variables.
Conclusion: In a large, muticenter cohort, CCTA measures of CAD severity and LVEF have independent prognostic value and LVEF had incremental 
value over routine clinical predictors and CAD severity in patients with suspected obstructive CAD.
